An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells

Summary.  Hepatitis B virus surface antigen (HBsAg), a specific antigen on the membrane of hepatitis B virus (HBV)‐infected cells, provides a perfect target for therapeutic drugs. In order to mediate successful targeted delivery of these therapies, it is essential to have antibodies that recognize HBsAg with high specificity and affinity. In this report, we constructed a natural immune antigen binding fragments (Fab) antibody phage display library against HBsAg and after three rounds of panning, five Fab fragments with significant HBsAg binding ability were selected and analysed. DNA sequencing revealed that all the light chains had the same sequence, while all the Fd genes exhibited different sequences. For further application, all of the Fab antibodies were reconstructed into single chain antibodies (scFvs) and expressed in Escherichia coli BL21 cells. Indirect enzyme‐linked immunosorbent assay analysis demonstrated that all five scFvs maintained a high affinity for HBsAg and could bind HBsAg on the membrane of HBV‐infected cells. Indirect fluorescent staining analysis revealed that one of the scFvs (scFv15) could be internalized into HBsAg‐positive HepG2.2.15 cells through clathrin‐mediated endocytosis pathway. The internalizing scFv15 antibody would have great potential for the targeted delivery of therapeutics to HBV‐infected cells.

[1]  T. Saibara,et al.  Hepatitis B surface antigen specific cytotoxic T lymphocyte activity in hepatitis B virus infection , 1985, Gastroenterologia Japonica.

[2]  T. Kojima.  Immune electron microscopic study of hepatitis B virus associated antigens in hepatocytes , 1982, Gastroenterologia Japonica.

[3]  J. Dienstag.  Looking to the Future: New Agents for Chronic Hepatitis B , 2006, The American Journal of Gastroenterology.

[4]  T. Wright.  Introduction to Chronic Hepatitis B Infection , 2006, The American Journal of Gastroenterology.

[5]  William M. Lee,et al.  Hepatitis B virus infection: current status. , 2005, The American journal of medicine.

[6]  Ding‐Shinn Chen,et al.  Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.

[7]  R. Gish.  Current treatment and future directions in the management of chronic hepatitis B viral infection. , 2005, Clinics in liver disease.

[8]  A. Rivkin.  A review of entecavir in the treatment of chronic hepatitis B infection , 2005, Current medical research and opinion.

[9]  Yongjun Jiao,et al.  Construction of human naïve fab library and characterization of anti-met fab fragment generated from the library , 2005, Molecular biotechnology.

[10]  D. Ludwig,et al.  Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth , 2005, Leukemia.

[11]  R. Guan.  Treatment of chronic hepatitis B infection using interferon. , 2005, The Medical journal of Malaysia.

[12]  M. Brigido,et al.  Construction of a human Fab phage display library from antibody repertoires of osteosarcoma patients. , 2005, Genetics and molecular research : GMR.

[13]  Robert P Perrillo,et al.  Current treatment of chronic hepatitis B: benefits and limitations. , 2005, Seminars in liver disease.

[14]  Suh-Chin Wu,et al.  Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization. , 2004, Vaccine.

[15]  D. Boger,et al.  A Human Single-Chain Antibody Specific for Integrin α3β1 Capable of Cell Internalization and Delivery of Antitumor Agents , 2004 .

[16]  D. Boger,et al.  A human single-chain antibody specific for integrin alpha3beta1 capable of cell internalization and delivery of antitumor agents. , 2004, Chemistry & biology.

[17]  Kyoichi Inoue,et al.  Interaction of lymphocytes with hepatocytes containing hepatitis B antigen: Ultrastructural demonstration of target antigen and T-cell subsets by the peroxidase antibody technique , 2004, Virchows Archiv A.

[18]  V. Quaranta,et al.  De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods. , 2003, Journal of immunological methods.

[19]  T. von Rüden,et al.  Antibody discovery: phage display. , 2002, Current opinion in biotechnology.

[20]  C. Ricci,et al.  Phage display and colony filter screening for high-throughput selection of antibody libraries. , 2002, Combinatorial chemistry & high throughput screening.

[21]  Hassan M E Azzazy,et al.  Phage display technology: clinical applications and recent innovations. , 2002, Clinical biochemistry.

[22]  R. Aitken,et al.  Broadening the impact of antibody phage display technology. Amplification of immunoglobulin sequences from species other than humans or mice. , 2002, Methods in molecular biology.

[23]  B. Xiao,et al.  Construction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancer. , 2001, World journal of gastroenterology.

[24]  S E Hufton,et al.  Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  I. Sanz,et al.  In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies. , 2000, International immunology.

[26]  A. Dürrbach,et al.  Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro , 1999, Cancer Gene Therapy.

[27]  Hennie R. Hoogenboom,et al.  A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies* , 1999, The Journal of Biological Chemistry.

[28]  I. Cooke,et al.  A combinatorial phage display library for the generation of specific Fab fragments recognizing human spermatozoa and inhibiting fertilizing capacity in vitro. , 1998, Biology of reproduction.

[29]  N. Bander,et al.  Constitutive and antibody-induced internalization of prostate-specific membrane antigen. , 1998, Cancer research.

[30]  A. L. Wong,et al.  Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. , 1996, Journal of immunology.

[31]  M. N. Williams,et al.  An antibody Fab selected from a recombinant phage display library detects deesterified pectic polysaccharide rhamnogalacturonan II in plant cells. , 1996, The Plant cell.

[32]  Y. Yarden,et al.  Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. T. Jones,et al.  Isolation of high affinity human antibodies directly from large synthetic repertoires. , 1994, The EMBO journal.

[34]  C. Barbas,et al.  Selection of human anti-hapten antibodies from semisynthetic libraries. , 1993, Gene.

[35]  W. Ouwehand,et al.  Human Antibody Fragments Specific for Human Blood Group Antigens from a Phage Display Library , 1993, Bio/Technology.

[36]  T Prospero,et al.  "Diabodies": small bivalent and bispecific antibody fragments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Voss,et al.  Molecular stabilization effects of interactions between anti-metatype antibodies and liganded antibody. , 1992, The Journal of biological chemistry.

[38]  D R Burton,et al.  A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Barbas,et al.  Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  V. Lingappa,et al.  Secreted hepatitis B surface antigen polypeptides are derived from a transmembrane precursor , 1988, The Journal of cell biology.

[41]  C. Chu,et al.  Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. , 1987, Gastroenterology.

[42]  R. Colvin,et al.  Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. , 1986, Transplantation.